Nirad
専門分野
Nirad Jain is a partner in Bain & Company's New York office. He co-leads Bain’s global Healthcare Private Equity and Corporate M&A practices.
Nirad has almost 20 years of management consulting experience, partnering with corporate clients and financial investors to drive results. He has led more than 200 client engagements across the healthcare value chain, including diligence, corporate M&A, transformation, performance improvement and strategy work in the services, payer, provider, medical device and pharmaceuticals sectors.
He has built significant expertise at the intersection of private equity and healthcare and is frequently cited in the media, including appearances on Bloomberg TV, The New York Times, The Wall Street Journal, Reuters, CNBC, Forbes, Buyouts and many others around the globe.
Prior to joining Bain in 2005, Nirad worked for another consulting confirm in New York, where he advised clients on growth and M&A strategies. He also previously worked in the not-for-profit sector.
Nirad holds an MBA from The Wharton School, a Master of Science from Stanford University and a Bachelor of Science, with honors, from Columbia University.
Recent Insights
- “Heady Competition for Healthcare Assets May Change the Route to Returns,” The PE Hub Network, 2019年4月24日, 記事
- “Letter from Kara Murphy and Nirad Jain,” レポート, 2019年4月17日
- “Year in Review: Healthcare Megadeals Lead the Way,” レポート, 2019年4月17日
- “Getting Healthcare Deals Done in a Crowded Market,” レポート, 2019年4月17日
- “North America: Ample Capital Pushes Deal Activity to Record Levels,” レポート, 2019年4月17日
- “Europe: Robust Activity Despite Long-Term Uncertainty,” レポート, 2019年4月17日
- “Asia-Pacific: Surging Consumer Demand for Healthcare,” レポート, 2019年4月17日
- “Providers: A Push into New Segments,” レポート, 2019年4月17日
- “Payers: Assets that Help Increase Operational Efficiencies,” レポート, 2019年4月17日
- “Biopharma: Strong Activity in the Face of Regulatory and Pricing Pressures,” レポート, 2019年4月17日